New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
09:19 EDTLAYN, ISIS, DARA, WFT, ETRM, AKS, ACMP, WMB, BLUE, LVLT, TWTC, SNDK, FIO, MDT, COVOn The Fly: Pre-market Movers
HIGHER: Covidien (COV), up 30% after Medtronic (MDT) agreed to acquire the company for $42.9B in cash and stock. Medtronic shares are also up 6% following the news... Fusio-io (FIO), up 24% after SanDisk (SNDK) to acquire the company in all-cash deal valued at approximately $1.1B... tw telecom (TWTC), up 11% after agreeing to be acquired by Level 3 (LVLT) for $40.86 per share. Level 3 shares are up 1% following the announcement... Bluebird bio (BLUE), up 63% after announcing data from a clinical study... Williams Companies (WMB), up 12.3% after Access Midstream (ACMP) confirms Williams' planned acquisition... AK Steel (AKS), up 5% after upgraded at BofA Merrill Lynch... Dara BioSciences (DARA), up 21% after KRN5500 granted orphan drug designation by FDA. LOWER: Weatherford (WFT), down 3% after holders approve change of jurisdiction from Switzerland to Ireland... Layne Christensen (LAYN), down 12% after reporting a greater than expected Q1 loss per share and lower than expected revenues.
News For COV;MDT;FIO;SNDK;TWTC;LVLT;BLUE;WMB;ACMP;AKS;ETRM;WFT;DARA;ISIS;LAYN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
October 14, 2014
07:04 EDTBLUEbluebird bio says first patient with sicle cell disease undergoes infusion
Subscribe for More Information
October 13, 2014
09:22 EDTMDTMedtronic announces positive data from CoreValve ADVANCE DA Study
Subscribe for More Information
07:37 EDTCOVAmerican Society of Anesthesiologists to hold annual meeting
Subscribe for More Information
07:25 EDTCOVEuropean Association of Cardiothoracic Surgery to hold annual meeting
28th EACTS Annual Meeting is being held in Milan, Italy on October 11-15.
07:13 EDTMDTBioFlorida to hold a conference
Subscribe for More Information
07:12 EDTISISOligonucleotide Therapeutics Society to hold annual meeting
Subscribe for More Information
October 10, 2014
10:29 EDTSNDKMicrochip CEO warning on industry correction sinks semiconductors
Shares of a number of semiconductor makers are falling sharply after one of the companies in the space, Microchip Technology (MCHP), warned that it believes the sector had entered a correction. In a note to investors today, research firm FBR Capital said Microchip's comments "could be worrisome, " and the firm responded by taking a more defensive stance on the space. WHAT'S NEW: Microchip, which develops microcontroller and analog semiconductors, estimated that its second quarter revenue would come in at $546.2M, versus its previous guidance of $560.0M-$575.9M and analysts' consensus estimate of $568M. The company said that it had experienced a number of negative trends during the quarter, including a weaker than usual September, weakness in China, and significant inventory builds at its distributor customers. Microchip President and CEO Steve Sanghi claimed his company often sees the turn of the semiconductor industry ahead of others, noting that it reports sales from distribution on a sell-through basis and built a significant amount of inventory in the distribution channel in the September quarter and that it does business with over 80,000 customers. Sanghi stated, "We believe that another industry correction has begun and that this correction will be seen more broadly across the industry in the near future. ANALYST REACTION: In a note to investors today, FBR Capital analyst Christopher Rolland said that Microchip's statements come in the wake of other negative signs for the sector. In August and September, lead times for the sector fell versus the month before, the analyst stated. Additionally, revenue trends at Taiwanese chip makers weakened in August, Rolland stated. The analyst said that Microchip's statements pushed him over the fence, causing him to take a more defensive stance on the sector. He removed ON Semiconductor (ONNN) from FBR's Top Picks list but kept an Outperform rating on the stock, as he believes that its valuation is "very reasonable." Rolland maintained Market Perform ratings on Atmel (ATML), Texas Instruments (TXN), Fairchild (FCS), AMD (AMD), and Applied Micro Circuits (AMCC). Sterne Agee also attributed weakness in the sector to Microchip's warnings, but the firm recommended buying NXP Semiconductors (NXPI), Avago (AVGO), and Skyworks (SWKS) due to their strong product cycles with EMV and upcoming iPhone-iPad launches from Apple (AAPL). In addition, the firm said it would buy Micron (MU) and SanDisk (SNDK) given tight supply, below normal inventory levels, and tailwinds from China. PRICE ACTION: In early trading, Microchip dropped nearly 14% to $39.29, Intel (INTC) fell almost 6% to $31.67, On Semiconductor slid 10% to $7.53, Atmel tumbled 11.5% to $6.61, Texas Instruments slipped 8% to $42.16, Fairchild slumped 10.6% to $12.95, AMD dropped 6% to $2.77, Applied Micro declined 10% to $6.19, and NXP Semiconductors was 14% lower to $55.27.
10:20 EDTSNDKSemiconductors defended at Sterne Agee
Subscribe for More Information
10:01 EDTWFTOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:00 EDTISISOn The Fly: Pre-market Movers
Subscribe for More Information
08:31 EDTWMBGoldman remains bullish on MLPs
Subscribe for More Information
07:16 EDTCOVAmerican Society of Plastic Surgeons to hold annual meeting
Annual Meeting of ASPS is being held in Chicago on October 10-14.
07:04 EDTMDT, COVMedtronic announces Omar Ishrak will remain CEO of new company
Subscribe for More Information
05:53 EDTWFTWeatherford upgraded to Buy from Hold at Societe Generale
Societe Generale upgraded Weatherford to Buy with a $24 price target.
05:22 EDTISISIsis Pharmaceuticals reports data from ISIS-SMN Rx Phase 2 study
Subscribe for More Information
October 9, 2014
16:37 EDTCOVCovidien receives FDA 510k clearance for Nellcor Portable SpO2 system
Covidien announced FDA 510k clearance for the Nellcor Portable SpO2 Patient Monitoring System. The system is the only commercially available portable oximeter that is equipped with home care and sleep study modes and complies with IEC 60601-1-11 standards for devices used in the home health care environment.
09:19 EDTSNDKSanDisk results should beat expectations, says RBC Capital
RBC Capital expects SanDisk to report stronger than expected results for its September quarter. The firm's estimates for SanDisk remain above those of the Street for the next few years because the firm is upbeat on the company's ability to move to higher margin markets. The firm keeps an $118 price target and Outperform rating on the shares.
08:57 EDTSNDKSanDisk's NAND ASPs trending below consensus, says ITG Research
ITG Research said SanDisk's NAND ASP's are trending below Q3 consensus of +.5% but sees bit consensus growth of +39% year-over-year as achievable.
08:40 EDTSNDKDiablo Technologies comments on Netlist injunction
Diablo Technologies commented on the announcement that Netlist (NLST) has filed a motion for preliminary injunction against the company and its technology partner SanDisk (SNDK), in an attempt to impede the manufacture and sale of the ULLtraDIMM product. Diablo stated, "Notably absent from Netlist's press release is the fact that their recent motion has abandoned much of their previous positioning. Netlist's recent amendments now limit their claims of lost sales to the NVvault. These changes can be attributed to Netlist's failure to substantiate claims in the so-called anonymous 'whistleblower' letter, on which they have based their case from the start. The request for a Preliminary Injunction will take months to resolve and Diablo will continue to deal with these baseless accusations in court. We view their latest move as a public relations stunt, which we will address in our existing claim against them." Diablo filed its defense and a counter claim against Netlist's unfair business practices on September 25.
07:02 EDTISISIsis Pharmaceuticals receives $18M milestone payment from GlaxoSmithKline
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use